ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,150.88
0.90%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Talis Biomedical Corporation (TLIS)

  7. Talis Biomedical Corporation (TLIS) News

Talis Biomedical (TLIS)

Talis Biomedical Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TLIS
DateTimeSourceHeadlineSymbolCompany
08/05/202413:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
26/01/202421:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
14/11/202313:00GlobeNewswire Inc.Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNASDAQ:TLISTalis Biomedical Corporation
01/09/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
10/08/202322:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TLISTalis Biomedical Corporation
10/08/202321:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
10/08/202321:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
10/08/202321:05GlobeNewswire Inc.Talis Biomedical Announces Second Quarter 2023 Financial Results and Business UpdateNASDAQ:TLISTalis Biomedical Corporation
03/08/202313:00GlobeNewswire Inc.Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023NASDAQ:TLISTalis Biomedical Corporation
02/08/202313:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202313:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202313:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
02/08/202313:00GlobeNewswire Inc.Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)NASDAQ:TLISTalis Biomedical Corporation
27/07/202313:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
27/07/202313:00GlobeNewswire Inc.New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product MenuNASDAQ:TLISTalis Biomedical Corporation
24/07/202313:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
24/07/202313:00GlobeNewswire Inc.Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:TLISTalis Biomedical Corporation
18/07/202322:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
05/07/202313:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
05/07/202313:00GlobeNewswire Inc.Talis Biomedical Announces 1-for-15 Reverse Stock SplitNASDAQ:TLISTalis Biomedical Corporation
13/06/202321:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
09/06/202321:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
23/05/202313:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
23/05/202313:00GlobeNewswire Inc.Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent DirectorNASDAQ:TLISTalis Biomedical Corporation
11/05/202321:38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
 Showing the most relevant articles for your search:NASDAQ:TLIS

Your Recent History

LSE
NG.
National Grid
LSE
POS
Plexus
LSE
ENET
Ethernity Networks
LSE
SRSP
Sirius Petroleum
LSE
VAST
Vast Resources
LSE
AVCT
Avacta
LSE
SCLP
Scancell
LSE
ZED
Zenova
LSE
LLOY
Lloyds Banking
LSE
CHLL
Chill Brands
LSE
SOS
Sosandar
LSE
TERN
Tern
LSE
AGL
Angle
LSE
KRS
Keras Resources
LSE
NFDS
Northern Foods
LSE
AAZ
Anglo Asian Mining
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved